Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ADBE, AMZN, UNH, GOOG, TPR, and represent 22.45% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: GOOG (+$269M), FB (+$161M), TWLO (+$124M), CPRT (+$109M), AAPL (+$100M), AMZN (+$92M), PTON (+$91M), Cano Health (+$87M), Vimeo (+$80M), Sofi Technologies (+$76M).
- Started 39 new stock positions in PTON, Sentinelone, Climate Change Crisis Cl A, BNTC, Cano Health, Graphite Bio, CPRT, Cano Health, AAPL, Mister Car Wash.
- Reduced shares in these 10 stocks: MCD (-$214M), DG (-$212M), DIS (-$212M), FIVE (-$149M), NKE (-$143M), SNAP (-$126M), CTLT (-$105M), PINS (-$105M), EL (-$99M), SQ (-$91M).
- Sold out of its positions in BMBL, CTLT, DIS, DG, FTCH, Finserv Acquisition Corp cl a, FSRXU, GH, LYFT, MCD. MILE, NKE, PINS, SNAP, SQ, TTWO, DSEY, Arya Sciences Acquisition, EBACU, HSAQ, HLXA, Jaws Acquisition Cl A Ord, Jaws Acquisition Corp, Social Cap Hedosop Hold V Cl A Ord.
- Suvretta Capital Management was a net seller of stock by $-229M.
- Suvretta Capital Management has $6.7B in assets under management (AUM), dropping by -1.12%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Companies in the Suvretta Capital Management portfolio as of the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Adobe Systems Incorporated (ADBE) | 5.6 | $372M | 635k | 585.64 | ||
| Amazon (AMZN) | 5.4 | $358M | +34% | 104k | 3440.16 | |
| UnitedHealth (UNH) | 4.1 | $277M | +25% | 692k | 400.44 | |
| Alphabet Cap Stk Cl C (GOOG) | 4.0 | $269M | NEW | 107k | 2506.32 | |
| Tapestry (TPR) | 3.4 | $225M | -3% | 5.2M | 43.48 | |
| Otis Worldwide Corp (OTIS) | 3.2 | $215M | -8% | 2.6M | 81.77 | |
| Union Pacific Corporation (UNP) | 3.1 | $210M | +4% | 957k | 219.93 | |
| Rh (RH) | 3.1 | $207M | -2% | 304k | 679.00 | |
| Mastercard Incorporated Cl A (MA) | 3.0 | $199M | +14% | 545k | 365.09 | |
| Uber Technologies (UBER) | 2.9 | $193M | -8% | 3.9M | 50.12 | |
| Lauder Estee Cos Cl A (EL) | 2.4 | $163M | -37% | 514k | 318.08 | |
| Medtronic SHS (MDT) | 2.4 | $161M | -4% | 1.3M | 124.13 | |
| Facebook Cl A (FB) | 2.4 | $161M | NEW | 463k | 347.71 | |
| Paysafe Ord (PSFE) | 2.3 | $156M | 13M | 12.11 | ||
Setup an alertSuvretta Capital Management will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
| Gfl Environmental Sub Vtg Shs (GFL) | 2.3 | $154M | +5% | 4.8M | 31.92 | |
| Carvana Cl A (CVNA) | 2.2 | $145M | 480k | 301.82 | ||
| Iqvia Holdings (IQV) | 2.2 | $144M | -29% | 595k | 242.32 | |
| Ross Stores (ROST) | 2.1 | $139M | 1.1M | 124.00 | ||
| AmerisourceBergen (ABC) | 2.0 | $135M | +34% | 1.2M | 114.49 | |
| Twilio Cl A (TWLO) | 1.9 | $124M | NEW | 314k | 394.16 | |
| Opendoor Technologies (OPEN) | 1.8 | $119M | +20% | 6.7M | 17.73 | |
| KBR (KBR) | 1.8 | $119M | -11% | 3.1M | 38.15 | |
| Quanta Services (PWR) | 1.7 | $115M | +12% | 1.3M | 90.57 | |
| Copart (CPRT) | 1.6 | $109M | NEW | 828k | 131.83 | |
| Anaplan (PLAN) | 1.6 | $107M | -26% | 2.0M | 53.30 | |
| Apple (AAPL) | 1.5 | $100M | NEW | 728k | 136.96 | |
| Peloton Interactive Cl A Com (PTON) | 1.4 | $91M | NEW | 734k | 124.02 | |
| Cano Health Com Cl A | 1.3 | $87M | NEW | 7.2M | 12.10 | |
| Fidelity National Information Services (FIS) | 1.3 | $85M | 600k | 141.67 | ||
| Nxp Semiconductors N V (NXPI) | 1.2 | $83M | -42% | 404k | 205.72 | |
| Te Connectivity Reg Shs (TEL) | 1.2 | $82M | -12% | 605k | 135.21 | |
| Vimeo Common Stock | 1.2 | $80M | NEW | 1.6M | 49.00 | |
| Foley Trasimene Acquistn Cor Com Cl A | 1.2 | $79M | +122% | 8.0M | 9.77 | |
| Sofi Technologies | 1.1 | $76M | NEW | 3.9M | 19.17 | |
| EXACT Sciences Corporation (EXAS) | 0.9 | $61M | -45% | 487k | 124.31 | |
| Invitae (NVTA) | 0.9 | $58M | +21% | 1.7M | 33.73 | |
| Howmet Aerospace (HWM) | 0.9 | $57M | NEW | 1.7M | 34.47 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $54M | -8% | 988k | 55.11 | |
| Analog Devices (ADI) | 0.8 | $54M | NEW | 312k | 172.16 | |
| Gores Holdings Vi Com Cl A (GHVI) | 0.6 | $43M | -3% | 2.7M | 16.21 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $42M | 1.0M | 40.82 | ||
| Natera (NTRA) | 0.6 | $40M | NEW | 354k | 113.53 | |
| Bluebird Bio (BLUE) | 0.6 | $40M | -3% | 1.3M | 31.98 | |
| Global Payments (GPN) | 0.6 | $39M | 207k | 187.54 | ||
| Kura Oncology (KURA) | 0.5 | $35M | +126% | 1.7M | 20.85 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.5 | $33M | 1.8M | 17.94 | ||
| Katapult Holdings | 0.5 | $33M | NEW | 3.0M | 10.81 | |
| Sutro Biopharma (STRO) | 0.5 | $32M | +33% | 1.7M | 18.59 | |
| Ajax I Cl A Ord (AJAX) | 0.4 | $30M | +38% | 3.0M | 9.96 | |
| Royalty Pharma Shs Class A (RPRX) | 0.4 | $30M | -23% | 729k | 40.99 | |
| Sentinelone Cl A | 0.4 | $30M | NEW | 701k | 42.50 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $29M | +24% | 1.2M | 23.96 | |
| Mereo Biopharma Group Ads (MREO) | 0.4 | $27M | +35% | 8.6M | 3.17 | |
| Revolution Accelertn Acqu Com Cl A (RAAC) | 0.4 | $25M | 2.5M | 9.97 | ||
| Mirati Therapeutics (MRTX) | 0.4 | $24M | NEW | 149k | 161.53 | |
| Deciphera Pharmaceuticals (DCPH) | 0.4 | $24M | +93% | 653k | 36.61 | |
| Heron Therapeutics (HRTX) | 0.3 | $23M | +194% | 1.5M | 15.52 | |
| Ambrx Biopharma Sponsored Ads | 0.3 | $23M | NEW | 1.2M | 19.60 | |
| Solid Biosciences (SLDB) | 0.3 | $22M | 6.0M | 3.66 | ||
| Therapeutics Acquisition Cor Com Cl A | 0.3 | $21M | +90% | 2.0M | 10.27 | |
| Altimeter Growth Corp Cl A (AGC) | 0.3 | $21M | NEW | 1.8M | 11.70 | |
| Fintech Acquisition Corp V Com Cl A (FTCV) | 0.3 | $20M | NEW | 1.7M | 12.19 | |
| Forte Biosciences (FBRX) | 0.3 | $17M | -13% | 517k | 33.62 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $17M | +6% | 1.6M | 10.48 | |
| Prometheus Biosciences (RXDX) | 0.2 | $15M | +8% | 626k | 24.56 | |
| Sio Gene Therapies Common (SIOX) | 0.2 | $15M | 5.5M | 2.73 | ||
| Bolt Biotherapeutics (BOLT) | 0.2 | $15M | +126% | 954k | 15.46 | |
| Aeglea Biotherapeutics (AGLE) | 0.2 | $15M | +53% | 2.1M | 6.96 | |
| Marqeta Class A Com | 0.2 | $14M | NEW | 504k | 28.07 | |
| Gemini Therapeutics (GMTX) | 0.2 | $14M | +62% | 2.1M | 6.47 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $14M | 1.1M | 12.26 | ||
| Chinook Therapeutics (KDNY) | 0.2 | $14M | +76% | 968k | 14.12 | |
| Blue Owl Capital Com Cl A | 0.2 | $13M | NEW | 1.0M | 12.88 | |
| Insmed Com Par $.01 (INSM) | 0.2 | $13M | NEW | 441k | 28.46 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $12M | +16% | 1.4M | 8.99 | |
| Holicity Com Cl A | 0.2 | $12M | NEW | 1.0M | 12.35 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $11M | +35% | 594k | 18.62 | |
| Finserv Acquisition Corp Ii Com Cl A | 0.2 | $11M | NEW | 1.1M | 9.73 | |
| Alussa Energy Acquisition Shs Cl A | 0.1 | $9.9M | 1.0M | 9.91 | ||
| Inflarx Nv (IFRX) | 0.1 | $9.8M | 3.3M | 2.97 | ||
| Turning Point Therapeutics I (TPTX) | 0.1 | $9.6M | NEW | 123k | 78.02 | |
| Molecular Partners Ads | 0.1 | $8.2M | NEW | 400k | 20.49 | |
| Kezar Life Sciences (KZR) | 0.1 | $7.7M | 1.4M | 5.43 | ||
| Newhold Investment Corp Com Cl A (NHIC) | 0.1 | $7.5M | 751k | 10.03 | ||
| Chimerix (CMRX) | 0.1 | $6.6M | -9% | 825k | 8.00 | |
| Inozyme Pharma (INZY) | 0.1 | $6.2M | +6% | 365k | 17.04 | |
| Verve Therapeutics | 0.1 | $6.0M | NEW | 100k | 60.25 | |
| Neximmune (NEXI) | 0.1 | $6.0M | -36% | 366k | 16.32 | |
| Five Below (FIVE) | 0.1 | $5.9M | -96% | 31k | 193.27 | |
| Otonomy (OTIC) | 0.1 | $5.3M | +15% | 2.4M | 2.23 | |
| Research Alliance Corp Ii Com Cl A (RACB) | 0.1 | $5.1M | 500k | 10.14 | ||
| Milestone Pharmaceuticals (MIST) | 0.1 | $4.7M | 851k | 5.50 | ||
| Fs Development Corp Ii Com Cl A (FSII) | 0.1 | $4.0M | 400k | 9.98 | ||
| Graphite Bio | 0.1 | $3.8M | NEW | 125k | 30.73 | |
| Cyteir Therapeutics | 0.1 | $3.7M | NEW | 175k | 21.40 | |
| Taboola.com Ord Shs | 0.1 | $3.6M | NEW | 350k | 10.35 | |
| Monte Rosa Therapeutics | 0.1 | $3.4M | NEW | 150k | 22.70 | |
| Benitec Biopharma (BNTC) | 0.0 | $3.3M | NEW | 769k | 4.25 | |
| Mister Car Wash | 0.0 | $3.2M | NEW | 150k | 21.53 | |
| Nautilus Biotechnology | 0.0 | $3.2M | NEW | 315k | 10.10 | |
| Climate Change Crisis Real I Cl A Com | 0.0 | $3.0M | NEW | 200k | 15.02 | |
| Omega Alpha Spac Cl A (OMEG) | 0.0 | $3.0M | 300k | 9.95 | ||
| Healthcor Catalio Acqu Corp Cl A Shs (HCAQ) | 0.0 | $3.0M | 300k | 9.85 | ||
| European Biotech Acqutn Corp Class A Ord Shs | 0.0 | $2.9M | NEW | 300k | 9.74 | |
| Adagene Ads (ADAG) | 0.0 | $2.8M | 204k | 13.56 | ||
| Cano Health *w Exp 06/03/202 | 0.0 | $2.5M | NEW | 675k | 3.69 | |
| Decibel Therapeutics (DBTX) | 0.0 | $2.3M | 264k | 8.60 | ||
| Bcls Acquisition Corp Com Cl A (BLSA) | 0.0 | $2.1M | 200k | 10.53 | ||
| Turmeric Acquisition Corp Cl A (TMPM) | 0.0 | $2.0M | 200k | 9.89 | ||
| Sana Biotechnology (SANA) | 0.0 | $2.0M | -85% | 100k | 19.66 | |
| Foley Trasimene Acquistn Cor *w Exp 05/26/202 | 0.0 | $1.6M | 774k | 2.08 | ||
| Elliott Opportunity Ii Corp Unit 99/99/9999 | 0.0 | $1.5M | NEW | 150k | 10.01 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.1M | 100k | 10.72 | ||
| Eucrates Biomedical Acqu Cor SHS (EUCR) | 0.0 | $984k | 100k | 9.84 | ||
| Foghorn Therapeutics (FHTX) | 0.0 | $896k | 84k | 10.67 | ||
| Frazier Lifesciences Acqu Cl A Shs (FLAC) | 0.0 | $854k | 88k | 9.76 | ||
| Finserv Acquisition Corp Ii *w Exp 02/17/202 | 0.0 | $328k | NEW | 273k | 1.20 | |
| European Biotech Acqutn Corp *w Exp 03/06/202 | 0.0 | $95k | NEW | 100k | 0.95 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 (TMPMW) | 0.0 | $61k | 67k | 0.92 | ||
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 (EUCRW) | 0.0 | $35k | 33k | 1.05 | ||
| Frazier Lifesciences Acqu *w Exp 11/30/202 (FLACW) | 0.0 | $32k | 29k | 1.10 | ||
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2021 Q2 filed Aug. 16, 2021
- Suvretta Capital Management 2021 Q1 filed May 17, 2021
- Suvretta Capital Management 2020 Q4 filed Feb. 16, 2021
- Suvretta Capital Management 2020 Q3 filed Nov. 16, 2020
- Suvretta Capital Management 2020 Q2 filed Aug. 14, 2020
- Suvretta Capital Management 2020 Q1 filed May 15, 2020
- Suvretta Capital Management 2019 Q4 filed Feb. 14, 2020
- Suvretta Capital Management 2019 Q3 filed Nov. 14, 2019
- Suvretta Capital Management 2019 Q2 filed Aug. 14, 2019
- Suvretta Capital Management 2019 Q1 filed May 15, 2019
- Suvretta Capital Management 2018 Q4 filed Feb. 14, 2019
- Suvretta Capital Management 2018 Q3 filed Nov. 14, 2018
- Suvretta Capital Management 2018 Q2 filed Aug. 14, 2018
- Suvretta Capital Management 2018 Q1 filed May 15, 2018
- Suvretta Capital Management 2017 Q4 filed Feb. 14, 2018
- Suvretta Capital Management 2017 Q3 filed Nov. 14, 2017